OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Release Date
2020
(2)
2018
(2)
2016
(2)
2025
(1)
2022
(1)
2019
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations.
Not available
S-EPMC5165695
|
biostudies-literature
Cite
Learning to encode cellular responses to systematic perturbations with deep generative models.
Not available
S-EPMC7648057
|
biostudies-literature
Cite
Explicit representation of protein activity states significantly improves causal discovery of protein phosphorylation networks.
Not available
S-EPMC7496209
|
biostudies-literature
Cite
Precision Oncology beyond Targeted Therapy: Combining Omics Data with Machine Learning Matches the Majority of Cancer Cells to Effective Therapeutics.
Not available
S-EPMC5821274
|
biostudies-literature
Cite
Tumour-specific Causal Inference Discovers Distinct Disease Mechanisms Underlying Cancer Subtypes.
Not available
S-EPMC6744493
|
biostudies-literature
Cite
Learning a hierarchical representation of the yeast transcriptomic machinery using an autoencoder model.
Not available
S-EPMC4895523
|
biostudies-literature
Cite
A novel truncated fusion gene
ETV6
::AC010198.2 in post-MPN acute myeloid leukemia caused by del(12)(p13p11).
Not available
S-EPMC11850314
|
biostudies-literature
Cite
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer.
Not available
S-EPMC6097104
|
biostudies-literature
Cite
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study.
Not available
S-EPMC9616883
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets